Implantable Cardioverter-Defibrillator in pediatrics and congenital heart disease: 20-years single center experience - 05/01/18
Résumé |
Background |
Despite increasing lifespan, sudden cardiac death remains a main cause of death in congenital heart diseases. Cardioverter-defibrillator implantation has been largely developed during last years in this population.
Purpose |
The aim of the study was to describe indications, implantation techniques, early and late complications in children and adult congenital heart disease implanted with Cardioverter-defibrillator in university hospital of Bordeaux since 20 years.
Methods |
We described the results of our cohort of young patients and congenital heart disease patients implanted with Cardioverter-defibrillator between 1994 and 2015, before age of 50, except coronary heart disease.
Results |
In total, 188 patients have been implanted in university hospital of Bordeaux 1994 and 2015. Most of the procedures were in primary prevention (n=106, 56%). Mean age at time of implantation was 30±10 years. Congenital heart diseases counted for 22% of implantations (n=41). There were five deaths during follow-up. Inappropriate shock rate was 12%.
Conclusion |
Advances in care of congenital heart disease allowed increased lifespan in this population. Adaptation to anatomic and physiologic specificities allowed decreasing device-related complications rates in these patients.
Le texte complet de cet article est disponible en PDF.Plan
Vol 10 - N° 1
P. 139 - janvier 2018 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?